Search for: "Sandoz, Inc" Results 101 - 120 of 680
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Aug 2015, 10:00 pm by Courtenay C. Brinckerhoff
Sandoz, Inc., the Federal Circuit affirmed the district court decision that upheld the validity of the Allergan patents relating to Lumigan® 0.01% glaucoma eye drops. [read post]
22 Mar 2015, 10:00 pm by Courtenay C. Brinckerhoff
Sandoz, Inc., ruling that the patent dispute resolution procedures of the Biologics Price Competition and Innovation Act (BPCIA) are optional. [read post]
7 Aug 2013, 11:00 pm by Daniel R. Shelton
Sandoz, Inc., the Federal Circuit invalidated a number of claims directed to a polymer... [read post]
18 Oct 2015, 10:00 pm by Courtenay C. Brinckerhoff
Sandoz Inc., which was the court’s first decision interpreting the Biologics Price Competition and Innovation Act (BPCIA). [read post]
18 Oct 2015, 10:00 pm by Courtenay C. Brinckerhoff
Sandoz Inc., which was the court’s first decision interpreting the Biologics Price Competition and Innovation Act (BPCIA). [read post]
6 Apr 2008, 7:25 pm
Sandoz, Inc. 3:08-cv-01584; filed March 31, 2008 in the District Court of Delaware Infringement... [read post]
15 Jun 2017, 10:00 pm
Post By Blog Staff On June 12, 2017, the Supreme Court released a decision in Sandoz Inc. v. [read post]
10 Nov 2015, 2:19 pm
Patent 6,500,829 (“the ‘829 patent’”) was invalid as obvious and that claims were not infringed by Sandoz’s Abbreviated New Drug Application (“ANDA”). [read post]
22 Feb 2010, 3:40 am by Ben Vernia
DOJ announced on February 22 that Eon Labs, Inc., a subsidiary of Sandoz, is paying $3.5 million to settle False Claims Act allegations regarding its statements concerning the regulatory status of nitroglycerin sustained release tablets. [read post]